Karyopharm Therapeutics
KPTI
KPTI
155 hedge funds and large institutions have $1.32B invested in Karyopharm Therapeutics in 2020 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 65 increasing their positions, 33 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
1% more capital invested
Capital invested by funds: $1.31B → $1.32B (+$13.4M)
0.04% more ownership
Funds ownership: 6.31% → 6.36% (+0.04%)
56% less funds holding in top 10
Funds holding in top 10: 9 → 4 (-5)
Holders
155
Holding in Top 10
4
Calls
$14.8M
Puts
$6.38M
Top Buyers
| 1 | +$25.6M | |
| 2 | +$20.1M | |
| 3 | +$19.7M | |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$18M |
| 5 |
D.E. Shaw & Co
New York
|
+$10.8M |
Top Sellers
| 1 | -$62.5M | |
| 2 | -$25.9M | |
| 3 | -$13M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$11.1M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$8.99M |